Randomised, Multicentre, Phase III, Open-Label Study of Alectinib vs Crizotinib in Treatment-Naïve Naplastic Lymphoma Kinase (ALK)-Positive Advanced NSCLC (ALEX Study)
Invited conference paper presented and published in conference proceedings

香港中文大學研究人員

全文

其它資訊
著者PETERS Solange, MOK Shu Kam Tony, PEROL Maurice, OU Sai Hong, ROSELL Rafael, BARA Ilze, HENSCHEL Volkmar, CAMIDGE D Ross
會議名稱39th ESMO Congress, 26-30 September 2014, Madrid, Spain
會議開始日27.09.2014
會議論文集題名39th ESMO Congress, 26-30 September 2014, Madrid, Spain
出版年份2014
月份9
日期27
頁次Poster Display Session Abst: 1334TiP
語言英式英語
關鍵詞NSCLC

上次更新時間 2018-22-01 於 21:20